4.5 Article

Diabetes related phenotypes and their influence on outcomes of patients with corona virus disease 2019 (COVID-19)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

RAAS inhibitors are associated with a better chance of surviving of inpatients with Covid-19 without a diagnosis of diabetes mellitus, compared with similar patients who did not require antihypertensive therapy or were treated with other antihypertensives

Mykola Khalangot et al.

Summary: This study assessed the risk of death in COVID-19 inpatients based on the presence or absence of diabetes mellitus, hypertension, and the use of RAAS inhibitors or other antihypertensives. The results showed that patients with diabetes had a higher mortality rate, while the use of RAAS inhibitors was associated with a lower risk of death.

FRONTIERS IN ENDOCRINOLOGY (2023)

Article Medicine, General & Internal

Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19 A Randomized Clinical Trial

Patrick R. Lawler et al.

Summary: In patients with COVID-19, overactivation of the renin-angiotensin system (RAS) may have negative clinical outcomes. This study aimed to determine if initiating angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) could improve outcomes in hospitalized COVID-19 patients. The results showed that in critically ill patients, the use of ACE inhibitors or ARBs did not improve, and likely worsened, clinical outcomes.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2023)

Review Medicine, General & Internal

The Significance of Low Magnesium Levels in COVID-19 Patients

Adorata Elena Coman et al.

Summary: Magnesium is a crucial mineral in the human body, particularly in the cardiovascular and respiratory systems. There is a potential link between magnesium deficiency and the pathophysiology of COVID-19. The disease primarily affects the respiratory system but can also involve other organs, leading to multiorgan failure. This review aims to summarize the available data on the role of magnesium in COVID-19 patients and its implications in different clinical scenarios.

MEDICINA-LITHUANIA (2023)

Article Endocrinology & Metabolism

Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status

Sunetra Mondal et al.

Summary: This study compared the effectiveness of admission-blood-glucose (ABG) and stress-hyperglycemia-ratio (SHR) in predicting mortality and adverse outcomes in COVID-19 patients. The results showed that SHR is a better predictor than ABG, regardless of the patients' pre-existing diabetic status.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Article Multidisciplinary Sciences

Mortality over time among COVID-19 patients hospitalized during the first surge of the pandemic: A large cohort study

Izabel Marcilio et al.

Summary: This retrospective cohort study conducted in Brazil's largest referral hospital for COVID-19 patients identified age, sex, comorbidity index, need for mechanical ventilation, and hospitalization period as risk factors associated with mortality among COVID-19 hospitalized patients.

PLOS ONE (2022)

Review Endocrinology & Metabolism

COVID-19 and diabetes-Two giants colliding: From pathophysiology to management

Maria Chiara Pelle et al.

Summary: The COVID-19 pandemic caused by SARS-CoV-2 has strained healthcare systems globally, with lockdowns being a main containment strategy. Despite advancements in vaccines and targeted therapies, patients with comorbid diabetes remain at higher risk for severe outcomes.

FRONTIERS IN ENDOCRINOLOGY (2022)

Article Biochemistry & Molecular Biology

Molecular and pro-inflammatory aspects of COVID-19: The impact on cardiometabolic health

Elena Lo Presti et al.

Summary: Obesity, type 2 diabetes, hypertension, and cardiovascular disease often coexist, forming cardiometabolic disease. During the COVID-19 pandemic, infected CMD patients are at a higher risk of severe damage due to overactivation of the immune system.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2022)

Review Endocrinology & Metabolism

Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews

Jamie Hartmann-Boyce et al.

Summary: The review found that diabetes is a risk factor for severe COVID-19 outcomes, especially for individuals with higher blood glucose levels and type 1 diabetes. However, there is a lack of data on whether diabetes predisposes individuals to SARS-CoV-2 infection.

DIABETES CARE (2021)

Article Endocrinology & Metabolism

Predictors of mortality in a multiracial urban cohort of persons with type 2 diabetes and novel coronavirus 19

Alyson K. Myers et al.

Summary: Diabetes is a risk factor for intubation and mortality in COVID-19 patients, with male gender, older age, and hyperglycemia at admission associated with increased mortality and intubation. Race, ethnicity, insurance type, and HbA1c did not show significant associations. Comorbid conditions like hypertension, chronic kidney disease, and coronary artery disease were associated with increased mortality. Blood glucose levels at admission have a greater impact on health outcomes than HbA1c. Older men and those with comorbid disease are also at greater risk for mortality.

JOURNAL OF DIABETES (2021)

Article Virology

COVID-19 In-Hospital Mortality in People with Diabetes Is Driven by Comorbidities and Age-Propensity Score-Matched Analysis of Austrian National Public Health Institute Data

Faisal Aziz et al.

Summary: Diabetes was associated with a higher likelihood of ICU admission in hospitalized COVID-19 patients, but advanced age and comorbidities, rather than diabetes itself, were linked to increased in-hospital mortality.

VIRUSES-BASEL (2021)

Review Endocrinology & Metabolism

Risk phenotypes of diabetes and association with COVID-19 severity and death: a living systematic review and meta-analysis

Sabrina Schlesinger et al.

Summary: This study aimed to identify high-risk phenotypes of diabetes associated with COVID-19 severity and death, showing that individuals with a more severe course of diabetes have a poorer prognosis of COVID-19 compared with individuals with a milder course of disease.

DIABETOLOGIA (2021)

Article Multidisciplinary Sciences

On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database

Fernanda Sumika Hojo de Souza et al.

Summary: This study analyzed the characteristics and mortality risk factors of hospitalized Brazilian COVID-19 patients, revealing a higher hospitalization rate among males and older patients, as well as a higher mortality rate among patients with cardiac disease, diabetes, and requiring invasive mechanical ventilation. The analysis also concluded that the disease outcome is influenced by multiple factors and disproportionately affects different population segments.

PLOS ONE (2021)

Article Medicine, General & Internal

Characteristics, outcomes and risk factors for mortality of 522 167 patients hospitalised with COVID-19 in Brazil: a retrospective cohort study

Marcia C. Castro et al.

Summary: This study provides a comprehensive description of demographic, clinical, and radiographic characteristics, as well as treatment outcomes, risk factors associated with in-hospital death of patients hospitalized with COVID-19 in Brazil. Results show that age, ethnoracial self-classification, ICU admission, gender, region of residence, and various comorbidities are significant risk factors for in-hospital death.

BMJ OPEN (2021)

Review Endocrinology & Metabolism

Insulin resistance in COVID-19 and diabetes

Nalini Govender et al.

Summary: COVID-19 infection can lead to insulin resistance in patients with diabetes, increasing the risk of mortality. Patients with diabetes are more susceptible to COVID-19, which may trigger chronic metabolic disorders after infection.

PRIMARY CARE DIABETES (2021)

Article Public, Environmental & Occupational Health

Higher risk of death from COVID-19 in low-income and non-White populations of SAo Paulo, Brazil

Sabrina L. Li et al.

Summary: In São Paulo state, Brazil, low-income, Black, and Pardo communities are more likely to die from COVID-19, attributed to differential access to quality healthcare, ability to self-isolate, and higher prevalence of comorbidities.

BMJ GLOBAL HEALTH (2021)

Review Endocrinology & Metabolism

COVID-19 and Diabetes: Understanding the Interrelationship and Risks for a Severe Course

Cyril P. Landstra et al.

Summary: The relationship between COVID-19 and diabetes is complicated and bidirectional. While diabetes is considered a major risk factor for severe COVID-19, the infection and its treatment can also worsen diabetes, leading to a cycle of negative impacts on both conditions. Challenges remain in understanding the interrelationship between COVID-19 and diabetes as more knowledge emerges during the pandemic.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Public, Environmental & Occupational Health

Factors Behind the Higher COVID-19 Risk in Diabetes: A Critical Review

Amany Magdy Beshbishy et al.

Summary: Diabetes mellitus and COVID-19 are global public health concerns, with the virus spreading through multiple pathways. Diabetic patients face higher risks of developing severe COVID-19 due to underlying disorders, highlighting the importance of strict glucose monitoring to prevent complications.

FRONTIERS IN PUBLIC HEALTH (2021)

Review Endocrinology & Metabolism

Sex differences in COVID-19: the role of androgens in disease severity and progression

Mohamed S. Mohamed et al.

Summary: Men are more affected by COVID-19, with androgen sensitivity potentially playing a crucial role in determining disease severity and predicting patient outcomes.

ENDOCRINE (2021)

Review Medicine, Research & Experimental

Endothelial activation and dysfunction in metabolic syndrome, type 2 diabetes and coronavirus disease 2019

Melvin R. Hayden

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities

Laura A. Bienvenu et al.

CARDIOVASCULAR RESEARCH (2020)

Review Endocrinology & Metabolism

Diabetes, infection risk and COVID-19

Suheda Erener

MOLECULAR METABOLISM (2020)

Article Multidisciplinary Sciences

COVID-19 hospitalizations in Brazil's Unified Health System (SUS)

Carla Lourenco Tavares de Andrade et al.

PLOS ONE (2020)